McKesson
MCKMarket price data through August 21, 2026.
Performance
Aug 2021 – Aug 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- +69%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$509
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- September 2024
- The month this stock first became a Benson pick.
- Tracking duration
- 23 months
- How long Benson has been tracking this pick.
About McKesson
McKesson is the company that gets medicine from drug makers to your local pharmacy, hospital, and cancer clinic. They run the delivery system that keeps prescriptions flowing across America, moving over 105 billion dollars of drugs and healthcare products in a single three month stretch.
The case for and against
Both sides of the story, in plain English.
- Profit Surge
McKesson just kicked off its new fiscal year with revenue up 8 percent to 105.4 billion dollars and adjusted earnings per share climbing 20 percent to 9.93 dollars. Leadership liked the start so much they raised their full year profit forecast to a range of 44.20 to 45 dollars per share.
- Cancer Engine
The oncology and multispecialty business grew revenue 33 percent to 14.2 billion dollars, with adjusted operating profit up 41 percent. As more cancer care moves to community clinics and specialty drugs keep growing, McKesson supplies the network that makes it happen.
- Penny Margins
Even with 105.4 billion dollars flowing through in one quarter, McKesson keeps barely a penny of profit on every dollar of sales. Reported earnings per share actually fell 1.10 dollars this quarter, showing how quickly one accounting charge can swamp the bottom line.
- Breakup Risk
McKesson is spinning off its medical supply business, now named Wellverse, after selling a 13 percent stake to Apollo for 1.25 billion dollars and taking on a 2.25 billion dollar loan to support the split. Big corporate breakups carry real execution risk, and the medical supply unit's adjusted profit already fell 20 percent.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-08-21. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch MCK for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.
Download on the App Store
Download Android app